Abstract
Estrogens are important regulators of growth and development and contribute to the etiology of several types of cancer. Different inbred rat strains exhibit marked, cell-type-specific differences in responsiveness to estrogens as well as differences in susceptibility to estrogen-induced tumorigenesis. Regulation of pituitary lactotroph homeostasis is one estrogen-regulated response that differs dramatically between different inbred rat strains. In this article we demonstrate that the growth response of the anterior pituitary gland of female ACI rats to 17β-estradiol (E2) markedly exceeds that of identically treated female Brown Norway (BN) rats. We further demonstrate that pituitary mass, a surrogate indicator of absolute lactotroph number, behaves as a quantitative trait in E2-treated F2 progeny generated in a genetic cross originating with BN females and ACI males. Composite interval mapping analyses of the (BN×ACI)F2 population revealed quantitative trait loci (QTLs) that exert significant effects on E2-induced pituitary growth on rat chromosome 4 (RNO4) (Ept5) and RNO7 (Ept7). Continuous treatment with E2 rapidly induces mammary cancer in female ACI rats but not BN rats, and QTLs that impact susceptibility to E2-induced mammary cancer in the (BN×ACI)F2 population described here have been mapped to RNO3 (Emca5), RNO4 (Emca6), RNO5 (Emca8), RNO6 (Emca7), and RNO7 (Emca4). Ept5 and Emca6 map to distinct regions of RNO4. However, Ept7 and Emca4 map to the same region of RNO7. No correlation between pituitary mass and mammary cancer number at necropsy was observed within the (BN×ACI)F2 population. This observation, together with the QTL mapping data, indicate that with the exception of the Ept7/Emca4 locus on RNO7, the genetic determinants of E2-induced pituitary growth differ from the genetic determinants of susceptibility to E2-induced mammary cancer.
Similar content being viewed by others
References
Aoki MP, Orgnero E, Aoki A, Maldonado CA (2003) Apoptotic cell death of oestrogen activated lactotrophs induced by tamoxifen. Tissue Cell 35:143–152
Blankenstein MA, Broerse JJ, van Zwieten MJ, Van Der Molen HJ (1984) Prolactin concentration in plasma and susceptibility to mammary tumors in female rats from different strains treated chronically with estradiol-17β. Breast Cancer Res Treat 4:137–141
Churchill GA, Doerge RW (1994) Empirical threshold values for quantitative trait mapping. Genetics 138:963–971
Clevenger CV, Furth PA, Hankinson SE, Schuler LA (2003) The role of prolactin in mammary carcinoma. Endocrine Rev 24:1–27
Clifton KH, Furth J (1961) Changes in hormone sensitivity of pituitary mammotropes during progression from normal to autonomous. Cancer Res 21:913–920
Couse JF, Korach KS (1999) Estrogen receptor null mice: what have we learned and where will they lead us? Endocrine Rev 20:358–417
Doerge RW (2002) Mapping and analysis of quantitative trait loci in experimental populations. Nat Rev Genet 3:43–52
Falconer DS, MacKay TFC (1996) Introduction to Quantitative Genetics, 4th edn. (Harlow, UK: Longman Group)
Goffin V, Binart N, Touraine P, Kelly PA (2002) Prolactin: the new biology of an old hormone. Annu Rev Physiol 64:47–67
Gould KA, Shull JD, Gorski J (2000) DES action in the thymus: inhibition of cell proliferation and genetic variation. Mol Cell Endocrinol 170:31–39
Gould KA, Tochacek M, Schaffer BS, Reindl TM, Murrin CR, et al. (2004) Genetic determination of susceptibility to estrogen-induced mammary cancer in the ACI rat: mapping of Emca1 and Emca2 to chromosomes 5 and 18. Genetics 168:2113–2125
Gould KA, Pandey J, Lachel CM, Murrin CR, Flood LA, et al. (2005) Genetic mapping of Eutr1, a locus controlling E2-induced pyometritis in the Brown Norway rat, to RNO5. Mamm Genome 16:854–864
Gould KA, Strecker TE, Hansen KK, Bynoté KK, Peterson KA, et al. (2006) Genetic mapping of loci controlling sensitivity to diethylstilbestrol-induced thymic atrophy in the Brown Norway rat. Mamm Genome 17:451–464
Hall JM, Couse JF, Korach KS (2001) The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 276:36869–36872
Harris J, Stanford PM, Oakes SR, Ormandy CJ (2004) Prolactin and the prolactin receptor: new targets of an old hormone. Ann Med 36:414–425
Harvell DME, Strecker TE, Tochacek M, Xie B, Pennington KL, et al. (2000) Rat strain specific actions of 17β-estradiol in the mammary gland: correlation between estrogen-induced lobuloalveolar hyperplasia and susceptibility to estrogen-induced mammary cancers. Proc Natl Acad Sci USA 97:2779–2784
Harvell DME, Strecker TE, Xie B, Buckles LK, Tochacek M, et al. (2001) Diet-gene interactions in estrogen-induced mammary carcinogenesis in the ACI rat. J Nutr 131:3087S–3091S
Harvell DME, Strecker TE, Xie B, Pennington KL, McComb RD, et al. (2002) Dietary energy restriction inhibits estrogen-induced mammary, but not pituitary, tumorigenesis in the ACI rat. Carcinogenesis 23:161–169
Harvell DM, Buckles LK, Gould KA, Pennington KL, McComb RD, et al. (2003) Rat strain specific attenuation of estrogen action in the anterior pituitary gland by dietary energy restriction. Endocrine 21:175–183
Heaney AP, Fernando M, Melmed S (2002) Functional role of estrogen in pituitary tumor pathogenesis. J Clin Invest 109:277–283
Holtzman S, Stone JP, Shellabarger CJ (1979) Influence of diethylstilbestrol treatment on prolactin cells of female ACI and Sprague-Dawley rats. Cancer Res 39:779–784
Korach KS, Emmen JM, Walker VR, Hewitt SC, Yates M, et al. (2003) Update on animal models developed for analyses of estrogen receptor biological activity. J Steroid Biochem Mol Biol 86:387–391
Lyle SF, Wright K, Collins DC (1984) Comparative effects of tamoxifen and bromocriptine on prolactin and pituitary weight in estradiol-treated male rats. Cancer 53:1473–1477
Manly KF, Olson JM (1999) Overview of QTL mapping software and introduction to map manager QT. Mamm Genome 10:327–334
Manly KF, Cudmore RH Jr, Meer JM (2001) Map Manager QTX, cross-platform software for genetic mapping. Mamm Genome 12:930–932
Meyer RK, Clifton KH (1956) Effect of diethylstilbestrol-induced tumorigenesis on the secretory activity of the rat anterior pituitary gland. Endocrinology 58:686–693
Pandey J, Wendell DL (2006) Angiogenesis and capillary maturation phenotypes associated with the Edpm3 locus on rat chromosome 3. Mamm Genome 17:49–57
Pandey J, Bannout A, Wendell DL (2004) The Edpm5 locus prevents the ‘angiogenic switch’ in an estrogen-induced rat pituitary tumor. Carcinogenesis 25:1829–1838
Pandey J, Gould KA, McComb RD, Shull JD, Wendell DL (2005) Localization of Eutr2, a locus controlling susceptibility to DES-induced uterine inflammation and pyometritis, to RNO5 using a congenic rat strain. Mamm Genome 16:865–872
Rose-Hellekant TA, Arendt LM, Schroeder MD, Gilchrist K, Sandgren EP, et al. (2003) Prolactin induces ERalpha-positive and ERalpha-negative mammary cancer in transgenic mice. Oncogene 22:4664–4674
Schaffer BS, Lachel CM, Pennington KL, Murrin CR, Strecker TE, et al. (2006) Genetic bases of estrogen-induced tumorigenesis in the rat: mapping of loci controlling susceptibility to mammary cancer in a Brown Norway x ACI intercross. Cancer Res 66:7793–7800
Sclafani RV, Wendell DL (2001) Suppression of estrogen-dependent MMP-9 expression by Edpm5, a genetic locus for pituitary tumor growth in rat. Mol Cell Endocrinol 176:145–153
Segaloff A, Dunning WF (1945) The effect of strain, estrogen, and dosage on the reaction of the rat’s pituitary and adrenal to estrogenic stimulation. Endocrinology 36:238-240
Shull JD (2002) Hormonal Carcinogenesis. In: Bertino JR (ed), Encyclopedia of Cancer vol 2 (San Diego, CA: Academic Press), pp 417–428
Shull JD, Spady TJ, Snyder MC, Johansson SL, Pennington KL (1997) Ovary intact, but not ovariectomized female ACI rats treated with 17b-estradiol rapidly develop mammary carcinoma. Carcinogenesis 18:1595–1601
Shull JD, Birt DF, McComb RD, Spady TJ, Pennington KL, et al. (1998) Estrogen induction of prolactin-producing pituitary tumors in the Fischer 344 rat: modulation by dietary energy, but not protein, consumption. Mol Carcinog 23:96–105
Shull JD, Pennington KL, Reindl TM, Snyder MC, Strecker TE, et al. (2001) Susceptibility to estrogen-induced mammary cancer segregates as an incompletely dominant phenotype in reciprocal crosses between the ACI and Copenhagen rat strains. Endocrinology 142:5124–5130
Spady TJ, Harvell DME, Snyder MC, Pennington KL, McComb RD, et al. (1998a) Estrogen-induced tumorigenesis in the Copenhagen rat: disparate susceptibilities to development of prolactin-producing pituitary tumors and mammary carcinomas. Cancer Lett 124:95–103
Spady TJ, Lemus-Wilson AM, Pennington KL, Blackwood DJ, Paschall TM, et al. (1998b) Dietary energy restriction abolishes development of prolactin-producing pituitary tumors in Fischer 344 rats treated with 17β-estradiol. Mol Carcinog 23:86–95
Spady TJ, Harvell DME, Lemus-Wilson A, Strecker TE, Pennington KL, et al. (1999a) Modulation of estrogen action in the pituitary and mammary glands by dietary energy consumption. J Nutr 129:587S–590S
Spady TJ, McComb RD, Shull JD (1999b) Estrogen action in the regulation of cell proliferation, cell survival, and tumorigenesis in the rat anterior pituitary gland. Endocrine 11:217–233
Spady TJ, Pennington KL, McComb RD, Birt DF, Shull JD (1999c) Estrogen induced pituitary tumor development in the ACI rat is not inhibited by dietary energy restriction. Mol Carcinog 26:239–254
Spady TJ, Pennington KL, McComb RD, Shull JD (1999d) Genetic bases of estrogen-induced pituitary growth in an intercross between the ACI and Copenhagen rat strains: dominant Mendelian inheritance of the ACI phenotype. Endocrinology 140:2828–2835
Stone JP, Holtzman S, Shellabarger CJ (1979) Neoplastic responses and correlated plasma prolactin levels in diethylstilbestrol-treated ACI and Sprague-Dawley rats. Cancer Res 39:773–778
Strecker TE, Spady TJ, Schaffer BS, Gould KA, Kaufman AE, et al. (2005) Genetic bases of estrogen-induced pituitary tumorigenesis: identification of genetic loci determining estrogen-induced pituitary growth in reciprocal crosses between the ACI and Copenhagen rat strains. Genetics 169:2189–2197
Tachibana M, Lu L, Hiai H, Tamura A, Matsushima Y, et al. (2006) Quantitative trait loci determining weight reduction of testes and pituitary by diethylstilbesterol in LEXF and FXLE recombinant inbred strain rats. Exp Anim 55:91–95
Tochacek M, Vander Woude EA, Spady TJ, Harvell DME, Snyder MC, et al. (2001) The ACI rat as a genetically defined animal model for the study of estrogen induced mammary cancers. In: Li JJ, Li SA, Daling JR (eds), Hormonal Carcinogenesis III (New York: Springer-Verlag), pp 471–476
Visscher PM, Thompson R, Haley CS (1996) Confidence intervals in QTL mapping by bootstrapping. Genetics 143:1013–1020
Wendell DL, Gorski J (1997) Quantitative trait loci for estrogen-dependent pituitary tumor growth in the rat. Mamm Genome 8:823–829
Wendell DL, Herman A, Gorski J (1996) Genetic separation of tumor growth and hemorrhagic phenotypes in an estrogen-induced tumor. Proc Natl Acad Sci U S A 93:8112–8116
Wendell DL, Daun SB, Stratton MB, Gorski J (2000) Different functions of QTL for estrogen-dependent tumor growth of the rat pituitary. Mamm Genome 11:855–861
Wendell DL, Pandey J, Kelley P (2002) A congenic strain of rat for investigation of control of estrogen-induced growth. Mamm Genome 13:664–666
Wiklund JA, Gorski J (1982) Genetic differences in estrogen-induced deoxyribonucleic acid synthesis in the rat pituitary: Correlations with pituitary tumor susceptibility. Endocrinology 111:1140–1149
Wiklund J, Rutledge J, Gorski J (1981a) A genetic model for the inheritance of pituitary tumor susceptibility in F344 rats. Endocrinology 109:1708–1714
Wiklund J, Wertz N, Gorski J (1981b) A comparison of estrogen effects on uterine and pituitary growth and prolactin synthesis in F344 and Holtzman rats. Endocrinology 109:1700–1707
Wright S (1968) The genetics of quantitative variability. In: Evolution and the genetics of populations: genetics and biometrical foundations (Chicago, IL: University of Chicago Press), pp 373–420
Zeng ZB (1993) Theoretical basis for separation of multiple linked gene effects in mapping quantitative trait loci. Proc Natl Acad Sci U S A 90:10972–10976
Zeng ZB (1994) Precision mapping of quantitative trait loci. Genetics 136:1457–1468
Acknowledgments
The authors thank Dr. Martin Tochacek, Dr. Mac McLaughlin, Ms. Amy Kaufman, Mr. Scott Kurz, Ms. Kimberly Bynoté, and Dr. Lisa Flood for their invaluable contributions to this research. This work was supported by National Institutes of Health grants R01-CA68529 (JDS) and R01-CA77876 (JDS). National Institutes of Health Cancer Center Support Grant P30-CA36727 supported shared resources within the UNMC Eppley Cancer Center. TES was supported in part by National Institutes of Health training grant T32-CA09476. BSS and TES were supported in part by training grant DAMD17-00-1-0361 from the U.S. Army Breast Cancer Training Program. BSS was supported in part by individual postdoctoral fellowship DAMD17-03-1-0477 from the U.S. Army Breast Cancer Training Program.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shull, J.D., Lachel, C.M., Murrin, C.R. et al. Genetic control of estrogen action in the rat: mapping of QTLs that impact pituitary lactotroph hyperplasia in a BN × ACI intercross. Mamm Genome 18, 657–669 (2007). https://doi.org/10.1007/s00335-007-9052-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00335-007-9052-2